Germany: Grunenthal issues €300m bond to take out Nebido acquisition loan

Germany: Grunenthal issues €300m to take out Nebido acquisition loan Grunenthal, a pharmaceutical company headquartered in Aachen, has priced €300m (US$328m) of 6.75% senior secured notes due 2030. The Reg S, 144a notes offering, rated BB+/BB-/B1 by Fitch/S&P/Moody’s, takes out the €200m loan facility established in 2022 to partially fund the Nebido acquisition, refinance its…